GPTHEALTH · NSE
GPT Healthcare Limited
₹166.21
+1.59% (+₹2.6)
Prev. close
₹163.61
Volume
3,19,398
Delivery %
45.8%
As of
18 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About GPT Healthcare Limited
GPT Healthcare Limited owns and operates a chain of hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology with renal transplants; laparoscopic and general surgery; critical care; pediatrics; gastroenterology; gynecology and obstetrics; interventional cardiology; orthopedics and joint replacement; neurosciences; and others. It also operates clinics and pharmacies, as well as the ILS Agartala Nursing Institute. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Dr. Om Prakash Tantia
Headquarters
Kolkata
Employees
2,124
Website
ilshospitals.comExchange
View on NSE ↗Key stats
Market cap
₹1,363.83 Cr
P/E ratio (TTM)
28.9
Dividend yield
1.83%
EPS (TTM)
₹5.76
Beta (1Y · daily vs NIFTY 50)
0.52
Shares float
2.69 Cr
EPS · quarter ended Jun 2026
₹1.55
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹358.32 Cr | ₹400.19 Cr | ₹407.09 Cr | ₹472.55 Cr | |
| EBITDA | ₹79.32 Cr | ₹93.13 Cr | ₹91.85 Cr | ₹90.13 Cr |
| ₹39.01 Cr | ₹47.77 Cr | ₹49.92 Cr | ₹42.22 Cr | |
| Diluted EPS | ₹4.75 | ₹5.96 | ₹6.08 | ₹5.15 |
Total expenses (as filed), Employee benefit expense, Other expenses, Other income have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| — | — | — | ₹326.76 Cr | ₹345.52 Cr | ₹384.25 Cr | ₹464.75 Cr | |
| — | — | — | ₹82.36 Cr | ₹30.54 Cr | ₹35.30 Cr | ₹91.18 Cr | |
| Stockholders' equity | — | — | — | ₹165.36 Cr | ₹218.49 Cr | ₹247.85 Cr | ₹269.43 Cr |
Total assets, Current assets, Inventory, Trade receivables, Cash & equivalents, Non-current assets, CWIP, Others, Total debt, Long-term debt, Current (short-term) debt, Stockholders' equity have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹66.36 Cr | ₹68.80 Cr | ₹67.40 Cr | ₹81.16 Cr | |
| Investing cash flow | ₹5.15 Cr | ₹-25.21 Cr | ₹-32.59 Cr | ₹-47.25 Cr |
| ₹-73.18 Cr | ₹-48.50 Cr | ₹-34.84 Cr | ₹-31.43 Cr | |
| Capital expenditure | ₹-9.95 Cr | ₹-19.37 Cr | ₹-49.93 Cr | ₹-41.82 Cr |
| End cash position | ₹6.60 Cr | ₹1.69 Cr | ₹1.66 Cr | ₹4.13 Cr |
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Feb 24–Jun 26(11Q) |
|---|---|
| Promoter | 65.57% |
| Public | 34.43% |
| Employee trusts | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,837.3 | 37.0 | 5.36 | 13.7% | 0.06 | +11.9% | +11.4% |
| Divi's Laboratories Limited | ₹2.47 L Cr | ₹9,375 | 83.3 | 14.77 | 15.3% | 0.00 | +12.3% | +53.4% |
| Torrent Pharmaceuticals Limited | ₹1.83 L Cr | ₹4,875 | 76.9 | 21.82 | 25.8% | 1.79 | +21.5% | +37.4% |
| Apollo Hospitals Enterprise Limited | ₹1.26 L Cr | ₹8,944.5 | 60.4 | 13.30 | 20.5% | 0.90 | +15.7% | +13.9% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹707.2 | 179.9 | 13.48 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.13 L Cr | ₹1,160 | 25.3 | 4.18 | 18.6% | 0.46 | +18.4% | +10.7% |
| Cipla Limited | ₹1.10 L Cr | ₹1,376.3 | 32.5 | 3.19 | 11.3% | 0.02 | +2.1% | -11.8% |
| Laurus Labs Limited | ₹1.05 L Cr | ₹1,954 | 96.4 | 19.86 | 16.8% | 0.48 | +22.0% | +111.6% |
| Max Healthcare Institute Limited | ₹1.01 L Cr | ₹1,049.3 | 69.8 | 9.39 | 13.4% | 0.32 | +19.0% | -10.6% |
| Dr. Reddy's Laboratories Limited | ₹97,876.16 Cr | ₹1,185 | 29.6 | 2.60 | 11.4% | 0.21 | +3.2% | -10.4% |
| Manipal Health Enterprises Limited | ₹97,364.22 Cr | ₹738.95 | 146.6 | 11.56 | 7.8% | 1.53 | +18.0% | — |
| GPT Healthcare Limited | ₹1,339.96 Cr | ₹163.61 | 28.4 | 4.97 | 15.7% | 0.34 | +16.5% | +7.0% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
IPO documents
Annual reports
Concall transcripts
Show all 11
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
2 indices
Weight is BSE’s own published index weight. Indices without weight data are listed without one, in alphabetical order after the weighted ones.